New

uMotif

The AI engine Fit Assessment

Beta

UMotif develops digital solutions for patient data capture and operates within the pharmaceutical industry, providing services to various stakeholders.

Blurb

UMotif is a scalable and engaging patient-centred data capture platform for modern research.

HQ Location

London (United Kingdom)

Founded

2012

Employees

51 - 200

Total funding raised

$37.05M

Funding Status

Series B, $25.17M, May 25, 2022

Putting patients first is in uMotif’s DNA. The modern uMotif eCOA platform delivers faster, high-quality clinical trials and real-world studies by putting patients at the core of research. Combined with uMotif’s robust site tools – including consent management, site productivity, and trial awareness – the platform strengthens the patient-site relationship, which is key to improving eCOA compliance and retention. With cloud hosting in the US, Europe, and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports all study phases and indications. Visit www.umotif.com